Corbus Pharmaceuticals Holdings, Inc.

CRBP

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001595097

SEC filings (opens in a new tab)

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of CRBP: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	101	4	108	+11
Shares	13.3M	1.07M	12.9M	+659.1K (+5.4%)
Value	$108.4M	$8.75M	$121.2M	+$21.5M (+21.6%)

4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to CRBP in Q1 2026
Institution	Shares	Value	% of portfolio
Vanguard Capital Management LLC	734,106	$6.89M	0.00%
Diadema Partners LP	439,957	$4.13M	1.71%
Vanguard Fiduciary Trust Co	96,241	$903.7K	0.00%
Simplex Trading, LLC	52,836	$496.1K	0.02%
Verdad Advisers, LP	50,252	$471.9K	0.53%
Rangeley Capital, LLC	44,840	$421.0K	0.46%
Cantor Fitzgerald, L. P.	40,098	$376.5K	0.01%
XTX Topco Ltd	38,023	$357.0K	0.01%
Vanguard Portfolio Management LLC	24,365	$228.8K	0.00%
Exchange Traded Concepts, LLC	22,131	$207.8K	0.00%
HRT Financial LP	18,660	$175.0K	0.00%
Bailard, Inc.	13,500	$126.8K	0.00%
Canada Pension Plan Investment Board	12,400	$116.4K	0.00%
Vanguard Global Advisers, LLC	4,695	$44.1K	0.00%
Tower Research Capital LLC (TRC)	684	$6.42K	0.00%
Golden State Equity Partners	100	$939	0.00%
Fortitude Family Office, LLC	64	$601	0.00%
National Bank of Canada	46	$428	0.00%
Clear Street Markets LLC	41	$385	0.00%
Newbridge Financial Services Group, Inc.	16	$150	0.00%
Advisory Services Network, LLC	14	$131	0.00%
Harbour Investments, Inc.	13	$122	0.00%
Cassaday & Co Wealth Management LLC	12	$113	0.00%
Fifth Third Bancorp	1	$9	0.00%

Sold out (13)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of CRBP in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Octagon Capital Advisors LP	955,000	$7.77M
Ameriprise Financial Inc	135,730	$1.10M
HealthInvest Partners AB	107,255	$873.1K
B. Riley Financial, Inc.	38,714	$315.1K
Trexquant Investment LP	27,275	$222.0K
Quest Partners LLC	22,906	$186.5K
Walleye Trading LLC	15,851	$129.0K
Two Sigma Investments, LP	12,480	$101.6K
Gsa Capital Partners LLP	11,056	$90.0K
Virtu Financial LLC	10,760	$88.0K
Avanza Fonder AB	4,868	$39.6K
Optiver Holding B.V.	929	$7.56K
Flagship Harbor Advisors, LLC	16	$130

Not filed for Q1 2026 yet (4)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRBP in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	859,407	$7.00M
Comerica Bank	200,001	$1.63M
Sherbrooke Park Advisers LLC	15,410	$125.4K
ORG Partners LLC	100	$814